| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.6B | $19.2B | $22.0B | $23.0B | $20.4B | $5.4B | $0.5B | $0.7B |
| Cost of Revenue | $19.5B | $19.1B | $20.6B | $20.5B | $15.9B | $5.1B | $1.4B | $1.5B |
| Gross Profit | — | — | — | — | — | — | $0.1B | $0.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.5B | $0.5B | $0.6B | $0.5B | $0.4B | $0.2B | $0.1B | $0.1B |
| Operating Income | $-1.6B | $-0.8B | $0.7B | $1.9B | $4.0B | $-0.1B | $0.4B | $0.7B |
| Net Income | $-1.5B | $-0.8B | $0.4B | $1.3B | $3.0B | $-0.1B | $0.3B | $0.6B |
| EPS (Basic) | $-2.91 | $-1.57 | $0.78 | $2.57 | $5.63 | $-0.32 | $0.23 | $2.06 |
| EPS (Diluted) | $-2.91 | $-1.57 | $0.78 | $2.55 | $5.36 | $-0.32 | $0.23 | $1.98 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.0B | $20.9B | $17.5B | $18.8B | $19.0B | $16.8B | $3.5B | $3.5B |
| Current Assets | $6.4B | $6.9B | $6.6B | $7.4B | $7.7B | $5.3B | $0.9B | $1.5B |
| Cash & Equivalents | $0.1B | $0.1B | $0.2B | $0.0B | $0.0B | $0.1B | $0.4B | $0.8B |
| Total Liabilities | $13.7B | $14.1B | $9.4B | $10.7B | $13.2B | $13.7B | $3.1B | $3.1B |
| Current Liabilities | $3.3B | $3.3B | $3.5B | $3.5B | $3.6B | $2.9B | $0.4B | $0.5B |
| Stockholders' Equity | $6.1B | $6.7B | $7.9B | $7.8B | $5.5B | $2.0B | — | $0.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.5B | $0.1B | $2.3B | $2.4B | $2.8B | $-0.3B | $0.6B | $0.5B |
| Investing Cash Flow | $-0.5B | $-3.2B | $-0.6B | $-0.9B | $-1.4B | $-2.0B | $-0.6B | $-0.3B |
| Capital Expenditures | $0.6B | $0.7B | $0.6B | $0.9B | $0.7B | $0.5B | $0.6B | $0.1B |
| Financing Cash Flow | $0.9B | $3.0B | $-1.5B | $-1.5B | $-1.5B | $2.1B | $-0.4B | $-0.4B |